HLA-D ANTIGENS IN INSULIN-DEPENDENT DIABETES
HLA-D ANTIGENS IN INSULIN-DEPENDENT DIABETES
批准号:
3447574
负责人:
DIMITRI S MONOS
金额:
$5.93万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 1991-01-31
中文摘要
本研究的目的是1)生物化学鉴定
英文摘要
The objectives of this study are 1) to biochemically identify the
specific gene products associated with the HLA-D region that
contribute to the susceptibility of Insulin Dependent Diabetes
(IDD) and 2) to study the expression of the biochemically
identified forms, as IDD specific on transfectant cells. This will
be accomplished by using cryopreserved cells and sera from a
large number of patients that have been collected and typed for
HLA class I and II antigens. In addition, a panel of 23B-lymphoid
cell lines (B-LCL) derived from 10 families will be utilized. The
study will consist of: 1) Characterization of HLA-DR and DO
alpha and beta subunits from B-LCL derived from IDD patient
carrying the HLA-DR3 and/or DR4 haplotypes by two dimensional
polyacrylamide gel electrophoresis (2D-PAGE), high pressure
liquid chromatography (HPLC) and restriction fragment analysis
of the DNA (RFLP). 2) Identification of combinatorial (hybrid)
DQ antigens forming unique Ia determinants generated as a result
of the association of the alpha and beta chains from two
haplotypes which can function as restriction elements conferring
susceptibility to IDD. 3) Identification of alloantibodies reactive
with IDD associated antigens in the sera of multiparous mothers
of IDD patients. 4) Isolation of the genes coding for the
molecular forms of DR or DO that the biochemical studies
indicated to be IDD specific and generation of transfectants
expressing these genes.
Information generated from this study will help to identify
molecular forms more frequently seen among IDD patients and
indirectly to use them as markers for identifying those at risk.
The transfectants generated will provide an excellent system for
studying the genetics of the susceptibility to IDD and will also
constitute a model for other Ia associated diseases.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
A novel method for generating stable high-level transfectants involving direct immunomagnetic selection for cell-surface epitopes: expression of HLA class-II genes in HeLa cells.
一种产生稳定高水平转染子的新方法,涉及细胞表面表位的直接免疫磁性选择:在 HeLa 细胞中表达 HLA II 类基因。
DOI:
10.1016/0378-1119(91)90440-m
发表时间:
1991
期刊:
Gene
影响因子:
3.5
作者:
[Kappes,DJ, Strominger,JL, Monos,DS]
通讯作者:
Monos,DS
Equine class II MHC antigens: identification of two sets of epitopes using anti-human monoclonal antibodies.
马 II 类 MHC 抗原:使用抗人单克隆抗体鉴定两组表位。
DOI:
10.1111/j.1399-0039.1989.tb01723.x
发表时间:
1989
期刊:
Tissue antigens
影响因子:
--
作者:
[Monos,DS, Wolf,B, Radka,SF, Rifat,S, Donawick,WJ, Soma,LR, Zmijewski,CM, Kamoun,M]
通讯作者:
Kamoun,M
HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.
DR4 单倍型的 HLA-DQw3.2 等位基因与胰岛素依赖型糖尿病相关;
DOI:
10.1007/bf00346526
发表时间:
1987
期刊:
Immunogenetics
影响因子:
3.2
作者:
[Monos,DS, Spielman,RS, Gogolin,KJ, Radka,SF, Baker,L, Zmijewski,CM, Kamoun,M]
通讯作者:
Kamoun,M
Atopic Dermatitis and High Resolution HLA
-
批准号:9550908
-
项目类别:
-
资助金额:$48.02万
-
财政年份:2017
-
负责人:DIMITRI S MONOS
-
依托单位:
Atopic Dermatitis and High Resolution HLA
-
批准号:9729537
-
项目类别:
-
资助金额:$54.5万
-
财政年份:2017
-
负责人:DIMITRI S MONOS
-
依托单位:
Atopic Dermatitis and High Resolution HLA
-
批准号:10310443
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2017
-
负责人:DIMITRI S MONOS
-
依托单位:
Atopic Dermatitis and High Resolution HLA
-
批准号:10063420
-
项目类别:
-
资助金额:$52.23万
-
财政年份:2017
-
负责人:DIMITRI S MONOS
-
依托单位:
Immunogenetics and Crohn's Disease
-
批准号:7041840
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2004
-
负责人:DIMITRI S MONOS
-
依托单位:
HLA-D ANTIGENS IN INSULIN-DEPENDENT DIABETES
-
批准号:3447573
-
项目类别:
-
资助金额:$5.78万
-
财政年份:1986
-
负责人:DIMITRI S MONOS
-
依托单位:
HLA-D ANTIGENS IN INSULIN-DEPENDENT DIABETES
-
批准号:3447572
-
项目类别:
-
资助金额:$5.77万
-
财政年份:1986
-
负责人:DIMITRI S MONOS
-
依托单位:
海外基金